Lipidomics

Lipidomics I read your recent article on lipids in The Scientist1 with great interest. I am a physician who studied for many years with Emanuel Revici, MD, a Romanian physician-scientist who lived from 1896 to 1998, and devoted his life to the study of lipids and their role in physiology and cancer. He created many of his own medicines, based on lipids, and, among many other things, identified the conjugated trienic fatty acids as "pathological" fatty acids 30 years before Bengt Samuelsson

Written byDwight Mckee
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I read your recent article on lipids in The Scientist1 with great interest. I am a physician who studied for many years with Emanuel Revici, MD, a Romanian physician-scientist who lived from 1896 to 1998, and devoted his life to the study of lipids and their role in physiology and cancer. He created many of his own medicines, based on lipids, and, among many other things, identified the conjugated trienic fatty acids as "pathological" fatty acids 30 years before Bengt Samuelsson received the 1982 Nobel prize in medicine for the discovery of leukotrienes. Revici also saw the importance selenium to cancer prevention in the 1930's.

Since Revici's work antedated the development of modern molecular biology technology, he developed many of his own analytical techniques, and envisioned a broadly conceptual model of the role of lipids in physiology and pathophysiology. His fundamental observation was that of a "dualism" in the physiology ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies